|Indications||For use in preventing Rh Immunization:
Pregnancy and other obstetrical conditions in Rh-negative women unless the father or baby are conclusively Rh-negative, e.g., delivery of an Rh-positive baby irrespective of the ABO groups of the mother and baby, any antepartum fetal-maternal hemorrhage (suspected or proven), actual or threatened pregnancy loss at any stage of gestation and ectopic pregnancy.
Prevention of Rh immunization in any Rh-negative in any Rh negative person after incompatible transfusion of Rh-positive blood or blood products.
|Viral Safety Process||Fractionation, filtration (Viresolve 180 ultra-filtration) and solvent/detergent treatment removes and inactivates both enveloped and non-enveloped viruses including Hepatitis A and West Nile.|
|Route of Administration||Intramuscular|
|Clearance of Rh-positive Red Blood Cells||15 mL packed red blood cells|
|Product Half-Life||30.9 days|
|Shelf Life||2 years from manufactured date|
|Supply Method||Pre-filled syringe, ready to use. 1 package insert, 1 control form, 1 patient identification card|
|Available Sizes||RhoGAM Ultra-Filtered PLUS package sizes:
MICRhoGAM Ultra-Filtered PLUS package sizes:
Return to Manufacturer Name listing Return to Factor Type listing